ProCE Banner Activity

Considerations for Front-Line Therapy: Selecting Optimal Therapy for Newly Diagnosed MM

Slideset Download
Download these slides from a live symposium for expert perspective on treatment considerations for patients with newly diagnosed MM.

Released: December 09, 2022

Expiration: December 08, 2023

No longer available for credit.

Share

Faculty

Philippe Moreau

Philippe Moreau, MD

Professor of Clinical Hematology
University Hospital of Nantes
Nantes, France

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Janssen administered by Scientific Affairs

Karyopharm Therapeutics Inc.

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc.

Takeda Pharm USA

Partners

International Myeloma Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Philippe Moreau, MD

Professor of Clinical Hematology
University Hospital of Nantes
Nantes, France